Central Pharmaceutical JSC No. 3

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 9.49% vs 27.57% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 223.90% vs -28.27% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "131,632.50",
          "val2": "120,227.70",
          "chgp": "9.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "82,911.70",
          "val2": "32,057.00",
          "chgp": "158.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "230.10",
          "val2": "169.60",
          "chgp": "35.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "74,574.30",
          "val2": "23,023.60",
          "chgp": "223.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "629.90%",
          "val2": "224.70%",
          "chgp": "40.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.90% vs 1.89% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 28.80% vs -3.27% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "437,926.90",
          "val2": "417,485.40",
          "chgp": "4.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "181,887.80",
          "val2": "149,130.80",
          "chgp": "21.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "694.70",
          "val2": "161.50",
          "chgp": "330.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-605.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "156,073.40",
          "val2": "121,171.60",
          "chgp": "28.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "388.80%",
          "val2": "327.40%",
          "chgp": "6.14%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

131,632.50

120,227.70

9.49%

Operating Profit (PBDIT) excl Other Income

82,911.70

32,057.00

158.64%

Interest

230.10

169.60

35.67%

Exceptional Items

0.00

0.00

Consolidate Net Profit

74,574.30

23,023.60

223.90%

Operating Profit Margin (Excl OI)

629.90%

224.70%

40.52%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 9.49% vs 27.57% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 223.90% vs -28.27% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

437,926.90

417,485.40

4.90%

Operating Profit (PBDIT) excl Other Income

181,887.80

149,130.80

21.97%

Interest

694.70

161.50

330.15%

Exceptional Items

0.00

-605.10

100.00%

Consolidate Net Profit

156,073.40

121,171.60

28.80%

Operating Profit Margin (Excl OI)

388.80%

327.40%

6.14%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 4.90% vs 1.89% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 28.80% vs -3.27% in Dec 2024

All Annual Results